Renasant Bio
Berkeley, US · Founded 2022 · Delaware corporation · 35 employees on LinkedIn · 4 known investors
Find your way into Renasant Bio
201 people in our graph share verified history with the Renasant Bio team — schools, employers, funds. One of them is your warm intro.
Abbie Celnikerunlockedknows Thomas Gustafson · together at University of Arizona College of Medicine – Tucson (overlapped)
knows the team · via Goldfinch Bio
knows the team · via TMRW Life Sciences
×6knows the team · via Stanford University School of Medicine
×2knows the team · via Medrio
knows the team · via University of Arizona College of Medicine – Tucson
Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD). Its pipeline targets the underlying biology of ADPKD across a range of mutations with the goal of halting and reversing disease progression.
Founders & leadership
Renasant Bio was founded in 2022 by Jeremy Reiter and Markus Delling.
JR
Jeremy ReiterScientific Co-Founder
MD
Markus DellingScientific Co-Founder
TG
Thomas GustafsoninChief Scientific OfficerThomas Gustafson is an executive officer at Renasant Bio with 25 years of experience in biopharmaceutical research, development, and business development, including expertise in rare kidney disease, metabolic disorders, and cardiovascular disease programs.
EC
Emily ConleyinCEOEmily Conley is an executive at Renasant Bio, a biopharmaceutical company developing therapies for autosomal dominant polycystic kidney disease. She previously joined 23andMe during its early growth phase and has authored over 35 academic publications in the biotech field.
Board
EC
CM
Charlotte McKeeBoard director
DP
Deborah PalestrantinMember Board of DirectorsPartner, Executive Chair, 4:59 Initiative at 5AM Ventures
AF
Anna FrenchinBoard Director
KB
NH
Natalie HollesinBoard Chair
Investors · 4
Reported raises · per SEC filings
Form D private placements$55.5M disclosed across 2 rounds · 2024–2025
▶$25.5MraisedJul 2025 · 3 investors · BiotechnologyRule 506(b)
▶$25.5MraisedJul 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Emily ConleyExecutive Officer, Director
- Deborah PalestrantDirector
- Evan CaplanDirector
- Thomas GustafsonExecutive Officer
- Kevin BittermanDirector
- June LeeDirector
- Offering amount
- $25.5M
- Amount sold
- $25.5M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$30MraisedJul 2025 · 4 investors · BiotechnologyRule 506(b)
▶$30MraisedJul 2025 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Evan CaplanDirector
- Natalie HollesDirector
- Charlotte McKeeDirector
- Deborah PalestrantDirector
- Thomas GustafsonExecutive Officer
- Anna FrenchDirector
- Kevin BittermanDirector
- Emily ConleyExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Renasant Bio went on to found or lead other companies.
Competitors · 6
by search overlap
Octant Bio8 shared keywordsOctant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
Radiant Biotherapeutics6 shared keywordsRadiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
Gannet BioChem5 shared keywordsGannet BioChem operates FDA-inspected cGMP manufacturing facilities in Alabama for polymer reagents, activated PEG compounds, and bulk pharmaceutical chemicals, serving research, clinical, and commercial programs at scales from grams to commercial volumes.
Guardant Health5 shared keywordsGuardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease. The company serves oncologists, patients, and biopharmaceutical firms with FDA-approved tests for cancer screening, early-stage risk assessment, and treatment selection.
Infinant Health4 shared keywordsInfinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants. The company operates in the infant health and microbiome therapeutics space.
Signant Health4 shared keywordsSignant Health provides software platforms and clinical trial solutions for life sciences companies to manage patient-reported outcomes, evidence generation, and digital endpoints in drug development programs across multiple therapeutic areas.
Companies competing with Renasant Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Renasant Bio do?
- Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD). Its pipeline targets the underlying biology of ADPKD across a range of mutations with the goal of halting and reversing disease progression.
- Who founded Renasant Bio?
- Renasant Bio was founded by Jeremy Reiter, Markus Delling in 2022.
- Who are Renasant Bio's investors?
- Renasant Bio's investors include 5AM Ventures, OrbiMed, Atlas Venture, Qiming Venture Partners USA.
- How much funding has Renasant Bio raised?
- Renasant Bio has disclosed $55.5M raised across 2 rounds.
- Where is Renasant Bio headquartered?
- Renasant Bio is headquartered in Berkeley, US.